Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02181
Species: Homo sapiens
Position : chr6:135418600-135418700
Year: 2016
Title: Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: acute myeloid leukemia
PMID:  27354268
MONDO: MONDO:0018874
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: KG-1a
CVCL ID: CVCL_1824
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay; Endogenous enhancer perturbation; Disease-variant functional analysis; In vivo functional validation
High Throughput Method: Targeted RNA-seq; GWAS
Low Throughput Method: CRISPR knockout, EMSA, RT-qPCR, Luciferase reporter assay, ChIP-qPCR, Western blot, Colony formation assay; CRISPR-Cas9 endogenous deletion/editing; In vivo phenotyping
About Target Gene
Target gene : MIR3662
About TF
TF name : GATA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA1 C-MYB transcription factor network pid 87
GATA1 Factors involved in megakaryocyte development and platelet production reactome 111
GATA1 IL3 netpath 84
GATA1 Notch-mediated HES/HEY network pid 48
GATA1 p73 transcription factor network pid 80
GATA1 Signaling events mediated by HDAC Class I pid 89
GATA1 Signaling events mediated by HDAC Class II pid 58
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_02256 chr6:135418600-135418700 blood NA acute myeloid leukemia
E_02264 chr6:135418600-135418700 NA hematopoietic progenitor cell NA
Expression of Target Genes for the Enhancer